We are live on ! Find out more

1,565 hedge funds and large institutions have $109B invested in Merck in 2013 Q4 according to their latest regulatory filings, with 187 funds opening new positions, 581 increasing their positions, 627 reducing their positions, and 70 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 187 | Existing positions closed: 70

46% more call options, than puts

Call options by funds: $1.39B | Put options by funds: $953M

7% more funds holding

Funds holding: 1,4691,565 (+96)

6% more capital invested

Capital invested by funds: $103B → $109B (+$5.89B)

0.21% more ownership

Funds ownership: 77.81%78.01% (+0.21%)

7% less repeat investments, than reductions

Existing positions increased: 581 | Existing positions reduced: 627

3% less funds holding in top 10

Funds holding in top 10: 117113 (-4)

Holders
1,565
Holders Change
+96
Holders Change %
+6.54%
% of All Funds
45.43%
Holding in Top 10
113
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-3.42%
% of All Funds
3.28%
New
187
Increased
581
Reduced
627
Closed
70
Calls
$1.39B
Puts
$953M
Net Calls
+$434M
Net Calls Change
+$103M
Name Holding Trade Value Shares
Change
Change in
Stake
SB
76
Suntrust Banks
Georgia
$231M +$1.14M +24,920 +0.5%
GE
77
General Electric
Ohio
$229M +$114M +2,490,703 +108%
PPA
78
Parametric Portfolio Associates
Washington
$228M +$5.22M +114,304 +2%
HSBC Holdings
79
HSBC Holdings
United Kingdom
$225M -$3.94M -86,296 -2%
JHIU
80
Janus Henderson Investors US
Colorado
$220M +$35.3M +773,145 +20%
SCCM
81
Schafer Cullen Capital Management
New York
$218M +$2.94M +64,215 +1%
MTB
82
Mizuho Trust & Banking
Japan
$217M +$1.71M +37,455 +0.9%
Loomis, Sayles & Company
83
Loomis, Sayles & Company
Massachusetts
$215M -$2.58M -56,385 -1%
Swiss National Bank
84
Swiss National Bank
Switzerland
$212M +$40.2M +879,900 +25%
Lazard Asset Management
85
Lazard Asset Management
New York
$209M -$8.86M -193,763 -4%
Adage Capital Partners
86
Adage Capital Partners
Massachusetts
$185M -$9.82M -214,840 -5%
BTS
87
BB&T Securities
Virginia
$182M +$3.7M +80,882 +27%
State of Wisconsin Investment Board
88
State of Wisconsin Investment Board
Wisconsin
$179M -$3.09M -67,596 -2%
TD Asset Management
89
TD Asset Management
Ontario, Canada
$178M +$3.63M +79,373 +2%
O
90
OppenheimerFunds
New York
$172M +$35.1M +767,958 +27%
BJ
91
BlackRock Japan
Japan
$169M -$22.9M -500,386 -12%
Citigroup
92
Citigroup
New York
$169M -$51.1M -1,117,160 -24%
Principal Financial Group
93
Principal Financial Group
Iowa
$167M -$1.4M -30,707 -0.9%
USAA
94
United Services Automobile Association
Texas
$167M -$4.02M -87,955 -2%
VOYA Investment Management
95
VOYA Investment Management
Georgia
$163M +$8.39M +183,519 +6%
SIM
96
Sprucegrove Investment Management
Ontario, Canada
$149M -$14.7M -321,107 -9%
CI
97
Cambiar Investors
Colorado
$145M +$3.02M +66,050 +2%
CI Investments Inc
98
CI Investments Inc
Ontario, Canada
$142M +$172K +3,773 +0.1%
SOMRS
99
State of Michigan Retirement System
Michigan
$139M -$120K -2,620 -0.1%
Victory Capital Management
100
Victory Capital Management
Texas
$137M -$35.2M -771,140 -21%

MRK Hedge Fund Activity: Q4 2013 in Review

1,565 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q4 2013, worth a combined $109B — up 5.7% from $103B a quarter earlier.

Buyers outnumbered sellers: 187 funds opened new MRK positions and 70 closed out — a net gain of 117 holders — while 581 added to existing stakes and 627 trimmed.

The largest buyer was Capital World Investors, adding an estimated $561M. The largest seller was Fidelity Investments, cutting an estimated $386M.

  • 1,565 institutional investors held Merck (MRK) as of Q4 2013, up from 1,469 in Q3 2013.
  • Funds reported $109B of Merck stock for Q4 2013, up 5.7% quarter-over-quarter.
  • 187 funds opened new Merck positions in Q4 2013 and 70 closed out, a net change of +117 holders.
  • The largest Merck buyer in Q4 2013 was Capital World Investors, an estimated $561M added.
  • The largest Merck seller in Q4 2013 was Fidelity Investments, an estimated $386M sold.

Based on aggregated 13F filings for Q4 2013.